Short-Term Outcome of Infliximab Therapy in Pediatric Crohn's Disease: A Single-Center Experience

PURPOSE: Studies on the efficacy of infliximab (IFX) in a large population of pediatric patients with Crohn's disease (CD) are limited, and prognostic factors are not well-known. The aim of this study was to evaluate outcomes of IFX in pediatric patients with CD and to identify factors associat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pediatr Gastroenterol Hepatol Nutr
Egile Nagusiak: Jung, Dai, Lee, Sunghee, Jeong, Insook, Oh, Seak Hee, Kim, Kyung Mo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2017
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750378/
https://ncbi.nlm.nih.gov/pubmed/29302505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5223/pghn.2017.20.4.236
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak